MONCTON, NB, May 31st, 2022 – Breathe BioMedical is pleased to announce the appointment of Don Hardison to the Board of Directors.
Don Hardison
Don has extensive leadership experience in executive positions as President and CEO of Biotheranostics, Good Start Genetics and EXACT Sciences. Don also has a wide range of experiences with companies including LabCorp, Quest Diagnostics and SmithKline Corporation. He currently sits on the boards of HTG Molecular, BioPorto, MDXHealth, YourBio Health, and Stemina Biomarker Discovery. His impressive background in the healthcare and clinical diagnostics space makes him a great asset to our team at Breathe BioMedical (BBM). Don understands the unique complexities of the medical field, allowing him to help guide and support our initiatives.
Don has a Bachelor of Political Science degree from the University of North Carolina.
“Since I first met the company, I was very impressed by the promise of collecting a breath sample and being able to perform different analyses related to oncology, Parkinson’s or other problematic diseases and disorders” says Don Hardison. “I think we have a chance to do something really special with a relatively simple sample source. It’s going to be hard work, but I’m impressed with the team and everyone I have met.”
Don’s healthcare expertise is found in complex healthcare reimbursement framework and processes, strategic development, team-building and go-to-market planning and execution. His many successful fundraising rounds exemplify his knowledge and mastery of improving and expanding companies. Don’s passion and extensive network will be great assets to our team at Breathe BioMedical.
“Don’s impressive track record at developing and commercializing groundbreaking biotechnologies speaks for itself,” says BBM’s Chairman of the Board, Jean Nadeau. “BBM’s disruptive potential is amazing. We are grateful to have a high-quality resource like Don informing BBM strategy and key decisions.”
# # #